ARTICLE | Distillery Therapeutics
Therapeutics: Dendritic cell-specific ICAM-3 grabbing nonintegrin (DC-SIGN; CD209)
August 6, 2015 7:00 AM UTC
Mouse studies suggest activating DC-SIGN could help treat pulmonary fibrosis and other fibrotic diseases. In a mouse model of acute lung inflammation, a small molecule activator of DC-SIGN decreased n...